Form 4: BrightSpring Health Services Director Matthew D'Ambrosio Acquires 1,000 Shares
SEC Form 4 Filing
Matthew D'Ambrosio, a director of BrightSpring Health Services, purchased 1,000 shares of common stock at $11.461 per share on May 20, 2024.
Summary
- On May 20, 2024, Matthew D'Ambrosio, a director of BrightSpring Health Services, Inc., acquired 1,000 shares of common stock.
- The purchase price was $11.461 per share.
- Following the transaction, Mr. D'Ambrosio beneficially owns 1,000 shares.
- Mr. D'Ambrosio is an executive of Walgreens Boots Alliance, Inc. and disclaims beneficial ownership of any BrightSpring Health Services securities that may be deemed beneficially owned by Walgreens affiliates.
Sentiment
Score: 5
Explanation: Neutral sentiment. This is a standard Form 4 filing indicating a director's stock purchase. It doesn't inherently convey strong positive or negative sentiment.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Management Comments
- Mr. D'Ambrosio disclaims beneficial ownership of any securities of the Issuer that may be deemed to be beneficially owned by affiliates of Walgreens.
Industry Context
This filing reflects routine trading activity by a company insider and provides limited insight into broader industry trends. However, insider transactions are always closely watched by investors for signals about management's view of the company's prospects.
Stakeholder Impact
- The stock purchase could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of stock purchase transaction |
| 05/21/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.